Valves in the Heart of the Big Apple V:
Evaluation and Management of Valvular Heart Diseases 2007

Conference Program
April 11, 2007 - April 14, 2007

Wednesday April 11, 2007
6:00 – 8:00 P.M. Registration
 
Thursday April 12, 2007
7:00 – 7:45 Registration and Continental Breakfast
7:45 – 7:55

Introduction and Symposium Goals
O. Wayne Isom, M.D., Jeffrey S. Borer, M.D.

7:55 – 8:00

Welcome from the American College of Cardiology
Paul Kligfield, M.D.
President, American College of Cardiology, New York State Chapter

8:00 – 8:05

Welcome from the Heart Valve Society of America
Jeffrey S. Borer, M.D.

OVERVIEW
Chairman: O. Wayne Isom, M.D.
(8:05 - 10:25)

8:05 – 8:25

THE HOWARD GILMAN FOUNDATION LECTURE Percutaneous Valve Replacement and Repair: Where Do We Stand —The Balance Between Investigator Enthusiasm and Regulatory Standards
Bram Zuckerman, M.D.

8:25 – 8:40

The epidemiology of valvular heart diseases: New data, new problems
Phyllis Supino, Ed.D .

8:40 – 8:55

Mechanisms of myocardial dysfunction in VHD: Impact on therapeutic decisions
Jeffrey S. Borer, M.D.

8:55 – 9:10

Proper pre-operative preparation of the patient with valvular heart disease to minimize anesthetic complications
Stephen Thomas, M.D.

9:10 – 9:25

Systolic and diastolic mechanics of valve disease: Implications for selection of therapy
Blase Carabello, M.D.

9:25 – 9:40

Age: Is it a selection factor for valve surgery?
Karl Krieger, M.D.

9:40 – 9:55

A lternative medicine strategies: What do they offer for the patient with VHD?
Mehmet Oz, M.D.

9:55 -10:25

Panel Discussion/Q & A
Chairman: O.Wayne Isom, M.D .; Panelists: Drs. Borer, Supino, Carabello, Oz, Thomas, Krieger, Zuckerman

10:25 – 10:55 Coffee Break/Posters

AORTIC VALVE DISEASE I
Chairman: Lawrence Cohn, M.D.
(10:55 - 12:30)

10:55 – 11:15

Anti-coagulation for prosthetic valves and AF: How do you do it and how do you interrupt it?
Valentin Fuster, M.D., Ph.D.

11:15 – 11:30

Operation for AS primarily in the asymptomatic patient: The time has come
Jamil Tajik, M.D.

11:30 – 11:45

We should provide statin prophylaxis for patients with AS: A critical appraisal of clinical data and their scientific basis Nalini Rajamannan, M.D.

11:45 – 12:00

Coronary disease and AS: When can you ignore the CAD? When should you perform a “hybrid” procedure?
Richard J. Shemin, M.D.

12:00 – 12:30

Panel Discussion/Q & A
Chairman: Lawrence Cohn, M.D. Panelists: Drs. Tajik, Shemin, Rajamannan, Fuster, Pai

12:30 – 2:00 Lunch
2:00 – 3:00

CASE PRESENTATIONS AND DISCUSSION
Chairman: Maurice E. Sarano, M.D

  • Mitral valve patient prosthesis mismatch.
  • Robotic valve surgery
  • Subvalvular aortic stenosis
  • Aortic stenosis in young man — The Ross Procedure
  • Infective endocarditis

Panel: Drs. Chen, Stelzer, McCarthy, Cohn, Oz, Pibarot, Tajik, Shemin, Herrold, Pai

AORTIC VALVE DISEASE II
Chairman: Mark Starling, M.D.
(3:00 - 4:15)

3:00 – 3:15

Drug prophylaxis for asymptomatic AR: Is it indicated?
Robert O Bonow, M.D.

3:15 – 3:30

Indication for operation AR: the symptomatic and asymptomatic patient
Jeffrey S. Borer, M.D .

3:30 – 3:45

Patient prosthetic mismatch: Implications for outcome in aortic valve disease
Philippe Pibarot, D.V.M., Ph.D.

3:45 – 4:00

Aortic valve replacement: valve selection to match patient to prosthesis
A. Mark Gillinov, M.D.

4:00 – 4:15

Apical-aortic conduit for aortic stenosis when ascending aortic calcification is severe
John Brown, M.D.

4:15 – 4:45 Coffee break/Posters

THE AORTIC ROOT AND ASSOCIATED VALVE DISEASE
Chairman: Richard J. Shemin, M.D.
(4:45 - 6:15)

4:45 – 5:15

Debate: When the aortic root is aneurismal and the aortic valve is incompetent, the valve should be repaired
Pro: Hartzell Schaff
Con: Leonard Girardi

5:15 – 5:30

Bicuspid aortic valve: exercise restriction, medication, root replacement — when is each appropriate?
John Elefteriadis , M.D.

5:30 – 5:45

Valve-sparing aortic root replacement
Alan Hilgenberg, M.D.

5:45 – 6:15

Panel Discussion/Q & A
Chairman: To be determined
Panelists: Drs Bonow, Schaff, Brown, Pibarot, Girardi, Elefteriadis, Hilgenberg, Brown, Gilinov, Pibarot, Starling, Borer

 
Friday April 13, 2007
7:00 – 7:45 Continental breakfast
7:45 – 10:30

SPLIT SESSION:

Session 1
Echocardiography
– current standards and techniques
Chairperson: Judy Hung, M.D.
Panelists: Drs. Tajik, Sarano, Goldman, St. John Sutton

Session 2
Surgical techniques and decisions

Chairman: O. Wayne Isom, M.D.
Panelists: Drs. Akins, Adams, Cohn, Elefteriadis, Galloway, Girardi, Herrold, Krieger, McCarthy, Sahn, Schaff

  • Mitral valve repair – non-ischemic
  • Minimally invasive aortic valve replacement
  • Mitral valve repair
  • Aortic root replacement with aortic valve repair
10:30 – 11:00 Coffee break/Posters

MITRAL REGURGITATION I
Chairman: A. Jamil Tajik, M.D.
(11:00 - 12:30)

11:00 – 11:15

Echocardiographic quantitation of MR
A. Jamil Tajik, M.D.

11:15 – 11:30

Indications for mitral valve surgery: impact of symptoms, ventricular function and atrial rhythm
Maurice E. Sarano, M.D.

11:30 – 11:45

Ventricular arrhythmias and MR: implications for timing of surgery and post-op care
Clare Hochreiter, M.D.

11:45 – 12:00

Prophylactic drug treatment for MR: beta blockade? vasodilatation? nothing?
Robert O Bonow, M.D.

12:00 – 12:30

Panel Discussion/Q & A
Chairman: A. Jamil Tajik, M.D. ; Panelists: Drs. Bonow, Goldman, Carabello, Hochreiter, Sarano, Starling

12:30 – 2:00

SPLIT SESSION LUNCH

Session A
Allied Health Professionals in VHD care
Chairpersons: Beth Eichhorn, RN; Jerene Bitondo, PA

  1. Home monitoring of INR: is the US behind the curve?
    Jerene Bitondo , PA
  2. Bridging anticoagulation for intercurrent procedures: is there a best approach?
    Warren Laskey, MD.
  3. Interpretation of hemodynamic data from catheterization
    Warren Laskey, M.D.
  4. Patient Education – materials and methods
    Beth Eichhorn, RN

Session B
Poster presentations of refereed abstracts

MITRAL REGURGITATION II
Chairman: David Adams, M.D.
(2:15 - 4:15)

2:15 – 2:45

Debate:
In patients with VHD, pulmonary vein isolation for AF should be reserved only for surgery
Pro: Charles Mack, M.D.
Con: Larry Chinitz, M.D.

2:45 – 3:00

Structural basis of ischemic MR – implications for therapy
Robert Levine, M.D.

3:00 – 3:15

Ischemic MR: when to operate
Maurice E. Sarano

3:15 – 3:30

Mitral valve replacement for MR: when is it still indicated?
Cary W. Akins, M.D.

3:30 – 3:45

Coronary Disease and MR – when do you fix both? How do you fix both?
David Adams, M.D.

3:45 – 4:15

Panel Discussion/Q & A
Chairman : David Adams, M.D. ; Panelists: Drs. Akins, Chinitz, Mack, Levine, Sarano, Starling

4:15 – 4:45 Coffee break/Posters

MITRAL REGURGITATION III AND TRICUSPID VALVE DISEASE
Chairman: Cary Akins, M.D.
(4:45 - 6:30)

4:45 – 5:15

Mitral regurgitation in cardiomyopathy should be managed medically
Pro: Blase Carabello, M.D.
Con: Steven F. Bolling, M.D.

5:15 – 5:30

Secondary MR is best treated with b iventricular pacing: a supportable strategy?
Martin G. St. John Sutton, M.D.

5:30 – 5:45

Infective endocarditis: scope of the problem and medical/surgical management strategy
Patrick J. O’Gara

5:45 - 6:00

When to correct tricuspid regurgitation
Patrick McCarthy

6:00 – 6:30

Panel Discussion/Q & A
Chairman: Cary Akins, M.D. ; Panelists: Drs. Carabello, Bolling, St. John Sutton, O’Gara, McCarthy, Starling

 
Saturday April 14, 2007
7:00 – 8:00 Continental breakfast

PERCUTANEOUS REPAIRS
Chairman: Jagat Narula, M.D.
(8:00 - 9:40)

8:00 – 8:20

Percutaneous mitral valve repair: current techniques and results
Ted Feldman

8:20 – 8:35

Re-operation for valve disease: impact of technical concerns on indications for re-operation and selection of procedures
Craig Smith, M.D.

8:35 – 8:55

Mitral stenosis: indications for mechanical therapy and comparative results of balloon valvulosplasty versus surgery
Igor F. Palacios, M.D.

8:55 – 9:10

Percutaneous aortic valve repair: techniques and current data
Allan Schwartz, M.D.

9:10 – 9:25

Percutaneous correction of asymmetric septal hypertrophy
Michael Fifer, M.D.

9:25 – 9:40

Clinical evaluation: Is there any place for symptom determination and physical examination in the world of echo evaluation and percutaneous therapy?
Shahbudin Rahimtoola, M.D.

9:40 – 10:05 Coffee break/Posters
10:05 -- 11:45

CASE PRESENTATIONS AND DISCUSSION
Chairman: Warren Laskey, M.D.

  • Infiltrative cardiomyopathy with MR
  • Long vegetation in IE
  • Radiation-induced valve disease
  • Rapid progression of LV size in AR
  • RV changes in MR
  • AS and AF
  • Tricuspid Flail Leaflet

Expert Panel: Drs. Sarano, Tajik, Fifer, Feldman, Smith, Narula, Palacios, Schwartz, Herrold

11:45 – 11:55 Closing Remarks
11:55– 12:00

Participants complete and submit course evaluation and CME form